Results 171 to 180 of about 3,526,344 (317)

Intelligent Automation Improved Efficiency in Pharmacovigilance Safety Signal Assessment

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance is the science involving the detection, assessment, understanding, and prevention of adverse events associated with drugs, biologics, or medical devices. In pharmacovigilance, information that suggests a new potential causal relationship between an intervention and an adverse event is called a safety signal. Following their detection,
Jeffrey Warner, Luis Henrique De Souza Teodoro, Anaclara Prada Jardim, Claudia Albera   +3 more
wiley   +1 more source

Defining the commercial tobacco industry in a changing nicotine landscape. [PDF]

Nicotine Tob Res
Maddox R, Henderson PN, Teddy L, Martinez SA, Hinds JT, Kennedy M, Guy MC.   +6 more
europepmc   +1 more source

Transcriptomic Profiling of SLC and ABC Transporters in the Human Term Placenta

Clinical Pharmacology &Therapeutics, EarlyView.
Solute carriers (SLC) and ATP‐binding cassette (ABC) transporters are essential for placental solute exchange and fetal protection, yet their transcriptomic profiles in the human placenta remain poorly characterized. Although fetal sex influences placental development and function, its impact on transporter expression is unclear.
Elijah Marsh Jung, Nicholas Ieronimakis, Bothaina Mousa, Emily D. Sheikh, Sarah E. Ligon, Joshua W. Monson, Jennifer R. Damicis, Hillary J. Kinsman, Lydia E. Bettridge, Samuel L.M. Arnold, Edward J. Kelly, Jashvant D. Unadkat, Joanne Wang   +12 more
wiley   +1 more source

Tobacco Industry and Cannabis: A New Public Health Challenge for Türkiye. [PDF]

Thorac Res Pract
Elbek O, Kılınç O.
europepmc   +1 more source

Tobacco Endgame &Tobacco Industry

Journal of the Korean Society for Research on Nicotine and Tobacco, 2022
openaire   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude, Cornelis Boersma, Peter G. M. Mol, Doranne Hilarius   +6 more
wiley   +1 more source

The policy implementation playbook: a cross-policy taxonomy of post-adoption tobacco industry tactics. [PDF]

Global Health
Matthes BK, Evans-Reeves K, Gatehouse T, Hiscock R, Fitzpatrick I, Gilmore AB.   +5 more
europepmc   +1 more source

Hosting the Tobacco Industry Supply Chain and Political Interference. [PDF]

Nicotine Tob Res, 2023
Hiscock R, Alaouie H, Matthes BK, Mehegan J, Bloomfield MJ.   +4 more
europepmc   +1 more source

Speaking About Artificial Intelligence for Sustainability—How Employees’ Perception of Credibility Shapes Their Initial Attitudes Toward AI Adoption

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Companies increasingly claim to adopt artificial intelligence (AI) not only for economic but also for ecological and social purposes. However, in light of rising greenwashing, bluewashing, and ethics washing, the impact of the communicated rationale on employees' initial attitude toward AI introduction remains unclear.
Marco Baumgartner, Tobias Kopp, Regina Kempen, Steffen Kinkel   +3 more
wiley   +1 more source

Tobacco industry interference with the point-of-sale advertising, promotion, and sponsorship ban near educational facilities in Armenia. [PDF]

Eur J Public Health
Hayrumyan V, Sargsyan Z, Petrosyan V.
europepmc   +1 more source